PLOD1 and polycystic ovary syndrome: The administration of a MYO and DCI combination proved to be effective in improving metabolic and hormonal parameters, reducing insulin, HOMA-IR, testosterone, and LH levels, as well as enhancing ovulatory function and increasing SHBG levels in women with PCOS [85].